Liver Cancer - Identifying and Commercializing First-in-Class Innovation; Market Report; Launched via MarketResearchReports.com
Globally, liver cancer is the sixth most common cancer, but its poor prognosis makes it the second leading cause of cancer-related death (Globocan, 2012). Currently, the range of therapies is limited; the market consisted entirely of chemotherapies for many years, and only recently have targeted therapies begun to emerge.
View full press release